Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osman F Güner

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Computer-Aided Drug Design|July 6, 2011
Pharmacophore modeling in drug design: recent advancesOsman F Güner
Current Topics in Medicinal Chemistry|December 10, 2002
History and evolution of the pharmacophore concept in computer-aided drug designOsman F Güner
Journal of Computer-Aided Molecular Design|December 7, 2005
Possibilities for transfer of relevant data without revealing structural informationOmoshile O Clement, Osman F Güner
Current Topics in Medicinal Chemistry|May 17, 2013
A perspective on quantum mechanics calculations in ADMET predictionsJ Phillip Bowen, Osman F Güner
Journal of Chemical Information and Modeling|April 22, 2014
Setting the record straight: the origin of the pharmacophore conceptOsman F Güner, J Phillip Bowen
Anticancer Research|October 2, 2019
Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidineNne E Uko, Osman F Güner, J Phillip Bowen, et al.
Current Topics in Medicinal Chemistry|February 25, 2020
Akt Pathway InhibitorsNne E Uko, Osman F Güner, Diane F Matesic, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2017
Substrate and inhibitor specificity of kynurenine monooxygenase from Cytophaga hutchinsoniiRobert S Phillips, Andrew D Anderson, Harvey G Gentry, et al.
Molecules (Basel, Switzerland)|January 11, 2022
The Kynurenine Pathway and Kynurenine 3-Monooxygenase InhibitorsTamera D Hughes, Osman F Güner, Emma Carine Iradukunda, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2018
Discovery and biological activity of computer-assisted drug designed Akt pathway inhibitorsNne E Uko, Osman F Güner, Lillie M A Barnett, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Computer-Aided Drug Design|July 6, 2011
Pharmacophore modeling in drug design: recent advancesOsman F Güner
Current Topics in Medicinal Chemistry|December 10, 2002
History and evolution of the pharmacophore concept in computer-aided drug designOsman F Güner
Journal of Computer-Aided Molecular Design|December 7, 2005
Possibilities for transfer of relevant data without revealing structural informationOmoshile O Clement, Osman F Güner
Current Topics in Medicinal Chemistry|May 17, 2013
A perspective on quantum mechanics calculations in ADMET predictionsJ Phillip Bowen, Osman F Güner
Journal of Chemical Information and Modeling|April 22, 2014
Setting the record straight: the origin of the pharmacophore conceptOsman F Güner, J Phillip Bowen
Anticancer Research|October 2, 2019
Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidineNne E Uko, Osman F Güner, J Phillip Bowen, et al.
Current Topics in Medicinal Chemistry|February 25, 2020
Akt Pathway InhibitorsNne E Uko, Osman F Güner, Diane F Matesic, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2017
Substrate and inhibitor specificity of kynurenine monooxygenase from Cytophaga hutchinsoniiRobert S Phillips, Andrew D Anderson, Harvey G Gentry, et al.
Molecules (Basel, Switzerland)|January 11, 2022
The Kynurenine Pathway and Kynurenine 3-Monooxygenase InhibitorsTamera D Hughes, Osman F Güner, Emma Carine Iradukunda, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2018
Discovery and biological activity of computer-assisted drug designed Akt pathway inhibitorsNne E Uko, Osman F Güner, Lillie M A Barnett, et al.
Pageof 2